[Treatment of left intraventricular XXXX with low molecular weight heparin].

@entity1 @entity882 @entity548 @entity35538 @entity384 @entity1188 @entity715 @entity2120 @entity1002
Following the discovery of a @entity1002 ( @entity1002 ), the classical approach consists of treatment with non-fractionated heparin (NFH) followed by oral anticoagulants. The use of NFH for this indication has only been evaluated in one open, non randomised study of 23 @entity1 with no control group. Low molecular weight heparins (LMWH) have not been the object of any study although they are routinely used by certain teams. The objective of this study was to evaluate the feasibility of the use of LMWH in the treatment of @entity1002 . This was an open, non randomised prospective study. All @entity1 having a newly diagnosed @entity1002 between September 2000 and September 2002 were treated with @entity2120 (100 IU/kg twice daily) for an average duration of 13 days; replacement with @entity35538 was started on the fifth day. The progression of the @entity1002 was followed using twice weekly transthoracic echocardiography for 3 weeks. RESULTS: 19 @entity1002 were discovered in 2 years (13 complicating an anterior @entity1188 and 6 with a @entity384 ). The average area was between 2.64 +/- 0.41 cm2 and 0.43 +/- 0.21 cm2 (p < 0.0001). Thirteen out of 19 thrombi disappeared with treatment (68.5%). There was no @entity882 or @entity548 . One transient ischaemic attack was noted. CONCLUSION: This preliminary work shows that LMWH are well tolerated and effective to make a @entity715 disappear or to reduce its size.
